Internal Medicine, Hematology & Oncology · New York, NY
NPI
1093771008
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
310 East 72nd Street
New York, NY, 10021
Phone (212) 650-1780
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$7.2M
1,396 prescriptions
Company payments, 2025
$472
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey Tepler prescribed most often to Medicare patients was Hydroxyurea, with 102 prescriptions and refills. In total Jeffrey Tepler wrote 1,396 Medicare prescriptions that cost $7.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxyurea Generic | 102 | 208 | 24 | $2,838 |
| Lenalidomide Generic | 96 | 96 | 12 | $1.3M |
| Eliquis Apixaban | 84 | 145 | 23 | $84K |
| Valacyclovir Valacyclovir Hcl | 71 | 172 | 19 | $4,605 |
| Tamoxifen Citrate Generic | 59 | 139 | 14 | $1,415 |
| Brukinsa Zanubrutinib | 54 | 54 | Under 11 | $789K |
| Revlimid Lenalidomide | 54 | 54 | Under 11 | $1.0M |
| Jakafi Ruxolitinib Phosphate | 51 | 51 | Under 11 | $1.0M |
| Ibrance Palbociclib | 44 | 44 | Under 11 | $728K |
| Xarelto Rivaroxaban | 35 | 67 | Under 11 | $37K |
| Imatinib Mesylate Generic | 32 | 32 | Under 11 | $3,482 |
| Pantoprazole Sodium Generic | 30 | 56 | 12 | $405 |
| Zarxio Filgrastim-Sndz | 28 | 28 | Under 11 | $55K |
| Anastrozole Generic | 28 | 84 | Under 11 | $794 |
| Procrit Epoetin Alfa | 27 | 29 | Under 11 | $106K |
Brand drugs: - claims; generic drugs: 843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey Tepler $472 ($472 in general payments such as food, travel and fees) from 10 companies. The largest payer was Seagen Inc. with $99.
| Company | Payments | Amount |
|---|---|---|
| Seagen Inc. PFE | 1 | $99 |
| Janssen Biotech, Inc. JNJ | 3 | $76.05 |
| Stemline Therapeutics Inc. | 3 | $59.69 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $52.26 |
| Celgene Corporation BMY | 3 | $48.75 |
| Octapharma USA, Inc. | 2 | $44.93 |
| Incyte Corporation INCY | 2 | $31.26 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.13 |
| Abbvie Inc. ABBV | 1 | $19.6 |
| Pfizer Inc. PFE | 1 | $16.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.